Oncoclínicas opens first Cancer Center in Brazil as an International Collaborative Member of Dana-Farber Cancer Institute
The estimated investment by Oncoclinicas in the new Cancer Center is BRL 93 million, including infrastructure, technology, and operations.
- The estimated investment by Oncoclinicas in the new Cancer Center is BRL 93 million, including infrastructure, technology, and operations.
- These facilities will be expanded to accommodate the new Oncoclínicas Cancer Center in Belo Horizonte e Nova Lima, an International Collaborative Member of Dana-Farber Cancer Institute.
- "The Oncoclínicas cancer center in Belo Horizonte is the first outside the United States to receive the designation of international collaborating member of the Dana Farber Cancer Institute.
- "Among other collaborative efforts, our multidisciplinary discussions contribute to democratizing cancer care for every patient across our operations in Brazil.